99 related articles for article (PubMed ID: 8058715)
1. HAM56 antibody: a tool in the differential diagnosis between colorectal and gynecological malignancy.
Younes M; Katikaneni PR; Lechago LV; Lechago J
Mod Pathol; 1994 Apr; 7(3):396-400. PubMed ID: 8058715
[TBL] [Abstract][Full Text] [Related]
2. Correspondence re: Mamoun Younes et al.: HAM56 antibody: a tool in the differential diagnosis between colorectal and gynecological malignancy. Mod Pathol 7:396, 1994.
Loy TS
Mod Pathol; 1995 Apr; 8(3):343-4. PubMed ID: 7617665
[No Abstract] [Full Text] [Related]
3. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma.
Berezowski K; Stastny JF; Kornstein MJ
Mod Pathol; 1996 Apr; 9(4):426-9. PubMed ID: 8729984
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma.
Loy TS; Calaluce RD; Keeney GL
Mod Pathol; 1996 Nov; 9(11):1040-4. PubMed ID: 8933513
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal anti-CEA antibodies in the discrimination between primary pulmonary adenocarcinoma and colon carcinoma metastatic to the lung.
Ghoneim AH; Brisson ML; Fuks A; Mobasher AA; Kreisman H
Mod Pathol; 1990 Sep; 3(5):613-8. PubMed ID: 2235987
[TBL] [Abstract][Full Text] [Related]
6. Is immunostaining with HAM56 antibody useful in identifying ovarian origin of metastatic adenocarcinomas?
Cheung AN; Chiu PM; Khoo US
Hum Pathol; 1997 Jan; 28(1):91-4. PubMed ID: 9013838
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary metastases of colonic carcinoma. Distinction from pulmonary adenocarcinoma.
Flint A; Lloyd RV
Arch Pathol Lab Med; 1992 Jan; 116(1):39-42. PubMed ID: 1734831
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical flow chart to differentiate between primary adenocarcinoma and the most frequent extragynecological metastases in the ovary].
Pires Y; Andrade L; Cuello M; Chuaqui R
Rev Med Chil; 2002 Nov; 130(11):1232-40. PubMed ID: 12587505
[TBL] [Abstract][Full Text] [Related]
9. Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium.
Shannon C; Kirk J; Barnetson R; Evans J; Schnitzler M; Quinn M; Hacker N; Crandon A; Harnett P
Clin Cancer Res; 2003 Apr; 9(4):1387-92. PubMed ID: 12684409
[TBL] [Abstract][Full Text] [Related]
10. Reactivity of monoclonal antibody F36/22 with human ovarian adenocarcinomas.
Croghan GA; Wingate MB; Gamarra M; Johnson E; Chu TM; Allen H; Valenzuela L; Tsukada Y; Papsidero LD
Cancer Res; 1984 May; 44(5):1954-62. PubMed ID: 6370421
[TBL] [Abstract][Full Text] [Related]
11. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
12. Necrosis in 84 ovarian carcinomas: a morphologic study of primary versus metastatic colonic carcinoma with a selective immunohistochemical analysis of cytokeratin subtypes and carcinoembryonic antigen.
DeCostanzo DC; Elias JM; Chumas JC
Int J Gynecol Pathol; 1997 Jul; 16(3):245-9. PubMed ID: 9421090
[TBL] [Abstract][Full Text] [Related]
13. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
Young RH
Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
[TBL] [Abstract][Full Text] [Related]
14. Ovarian carcinomas, including secondary tumors: diagnostically challenging areas.
Prat J
Mod Pathol; 2005 Feb; 18 Suppl 2():S99-111. PubMed ID: 15492758
[TBL] [Abstract][Full Text] [Related]
15. The role of L1-CAM immunohistochemial staining in the diagnosis of abdominal-pelvic cancer of uncertain primary site in women.
Ben-Arie A; Huszar M; Ben-Zvi N; Smirnov A; Altevogt P; Fogel M
Eur J Surg Oncol; 2008 Jul; 34(7):795-9. PubMed ID: 17845837
[TBL] [Abstract][Full Text] [Related]
16. Use of antibodies against estrogen and progesterone receptors to identify metastatic breast and ovarian carcinomas by conventional immunohistochemical and tyramide signal amplification methods.
Kaufmann O; Köther S; Dietel M
Mod Pathol; 1998 Apr; 11(4):357-63. PubMed ID: 9578086
[TBL] [Abstract][Full Text] [Related]
17. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary.
Park SY; Kim HS; Hong EK; Kim WH
Hum Pathol; 2002 Nov; 33(11):1078-85. PubMed ID: 12454811
[TBL] [Abstract][Full Text] [Related]
18. Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification.
Yemelyanova AV; Vang R; Judson K; Wu LS; Ronnett BM
Am J Surg Pathol; 2008 Jan; 32(1):128-38. PubMed ID: 18162780
[TBL] [Abstract][Full Text] [Related]
19. Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement.
Judson K; McCormick C; Vang R; Yemelyanova AV; Wu LS; Bristow RE; Ronnett BM
Int J Gynecol Pathol; 2008 Apr; 27(2):182-90. PubMed ID: 18317225
[TBL] [Abstract][Full Text] [Related]
20. Differences in AgNOR quantity between colorectal cancer and corresponding metastases: are they useful for prognostic purposes?
Giuffrè G; Barresi G; Speciale G; Sarnelli R; Gioffrè Florio MA; Tuccari G
Eur J Histochem; 1997; 41(2):111-8. PubMed ID: 9271703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
